Research Study for adults with Ulcerative Colitis

IRB/UVA Tracking #
18268
Principal Investigator
Behm Brian,
Contact
Harriette Wheatley
Contact Email
Contact Phone
434.924.4178
Official Trial Title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis (RPC01-3101)
Study Description

The Division of Gastroenterology (GI) is investigating an experimental drug for adults, ages 18-75, with Ulcerative Colitis. After a screening period, eligible participants will take the study drug or placebo for one year. There will be 11 study visits at UVA.

Compensation

$50/study visit